Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Interferons and cancer therapy.

T J Priestman

    The Journal of Pathology
    |November 1, 1983
    PubMed
    Summary
    This summary is machine-generated.

    Human interferons, including alpha, beta, and gamma types, have been studied. Early clinical trials with alpha-interferon showed disappointing results, prompting research into combination therapies.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The Royal College of Radiologists' fractionation survey. 1989.

    Clinical oncology (Royal College of Radiologists (Great Britain))·2014
    Same author

    Controlling the toxicity of palliative radiotherapy: the role of 5-HT3 antagonists.

    The Canadian journal of oncology·1996
    Same author

    The role of palliative radiotherapy for bone metastases.

    The Canadian journal of oncology·1996
    Same author

    Palliative radiotherapy in the UK.

    The Canadian journal of oncology·1996
    Same author

    Final results of the Royal College of Radiologists' trial comparing two different radiotherapy schedules in the treatment of cerebral metastases.

    Clinical oncology (Royal College of Radiologists (Great Britain))·1996
    Same author

    Lymphoma of the prostate treated with radiotherapy.

    Clinical oncology (Royal College of Radiologists (Great Britain))·1995
    Same journal

    Tumor Invasive Border Index (TIBI) in colorectal cancer: linking infiltrative morphology to molecular insights.

    The Journal of pathology·2026
    Same journal

    Lipodystrophy and adipose tissue recovery are mediated by the Wnt/lipogenesis axis during skin fibrosis.

    The Journal of pathology·2026
    Same journal

    Optical mapping reveals a higher level of large-scale structural variants in a family with paternally transmitted myotonic dystrophy and independent Parkinson's disease.

    The Journal of pathology·2026
    Same journal

    FTO-mediated m6A modification of protein disulfide-isomerase activates VEGFA-VEGFR2 to suppress programmed cell death in osteosarcoma.

    The Journal of pathology·2026
    Same journal

    Dopamine inhibits retinal pathological neovascularization in the oxygen-induced retinopathy mouse model.

    The Journal of pathology·2026
    Same journal

    Aberrant alternative splicing of purinergic receptor P2RX4 prevents sensitivity towards combinatorial treatment in colorectal and pancreatic cancer.

    The Journal of pathology·2026
    See all related articles

    Area of Science:

    • Immunology
    • Oncology
    • Biochemistry

    Background:

    • Human interferons (IFNs) are cytokines with antiviral and antitumor properties.
    • Alpha, beta, and gamma interferons are distinct types of IFNs.
    • Three subtypes of alpha-interferon underwent clinical evaluation.

    Purpose of the Study:

    • To review the clinical assessment of alpha-interferon subtypes.
    • To evaluate the efficacy of interferons in cancer treatment.
    • To explore alternative therapeutic strategies involving interferons.

    Main Methods:

    • Clinical trial data analysis.
    • Review of existing literature on interferon therapy.
    • Exploration of combination treatment protocols.

    Related Experiment Videos

    Main Results:

    • Clinical assessments of alpha-interferon subtypes yielded disappointing outcomes.
    • Monotherapy with alpha-interferon did not meet therapeutic expectations.
    • Limited efficacy observed in initial trials.

    Conclusions:

    • The direct clinical application of alpha-interferon as a standalone treatment has shown limited success.
    • Future therapeutic strategies should focus on combining interferons with conventional cytotoxic agents.
    • Combination therapy represents a promising avenue for enhancing interferon efficacy.